Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1034 of 5804
-
New combo aims to slow lung scarring in IPF patients
Disease control Not yet recruitingNintedanib combined with or without Dextromethorphan for the treatment of IPF, with FVC as the primary efficacy endpoint to evaluate its effectivenes.
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Heart stent showdown: which technique wins for left main blockages?
Disease control Recruiting nowCoronary artery disease is a leading cause of mortality and morbidity globally. The left coronary artery system is critically important due to its supply of a large area of myocardium. Ostia lesions of left anterior descending artery \[LAD\] and circumflex artery \[CX\]) present …
Sponsor: Istanbul Mehmet Akif Ersoy Educational and Training Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Experimental cocktail aims to shrink liver tumors in tough colorectal cancer
Disease control Recruiting nowThis is a single-arm pilot feasibility study evaluating the combination of Botensilimab and Balstilimab with Radiation Therapy (RT) in Non-Microsatellite Instability High (MSI-H) or Proficient Mismatch Repair (pMMR) chemorefractory colorectal cancer (CRC) with liver metastasis.
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo aims to tame painful muscle condition and cut steroid dependence
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled, parallel-group, Phase 4, 3-group study to assess whether treatment with sarilumab at either 150 mg q2w (once every two weeks) or at 200 mg q2w, each given with a 52-week prednisone taper, is superior to placebo given with a …
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
3D colonoscopy may sharpen cancer detection
Diagnosis Not yet recruitingColorectal cancer (CRC) is one of the most common cancers worldwide. These malignancies originate in the colon or rectum, and the majority evolve from pre-existing colonic adenomas (a type of colon polyp). Early detection, identification, and removal of these precancerous lesions…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New stroke care program aims to cut complications and boost recovery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether a multicomponent nurse-led intervention (BEST CARE ICTUS\_HC) can reduce stroke-related complications and improve recovery in adults (18 years and older) hospitalized with an acute ischemic or hemorrhagic stroke in hospitals …
Phase: NA • Sponsor: University of Malaga • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug combo aims to protect kidneys in heart patients
Disease control Recruiting nowIn this study, investigators will compare the effect of vicadrostat combined with empagliflozin with the effect of spironolactone combined with empagliflozin on renal function and changes in protein profiles in blood and urine. The hypothesis is that the renal and cardiac respon…
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a sleep machine stop heart rhythm problems after ablation?
Disease control Recruiting nowAtrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remain substantial, ranging from 20% to 45%. Previous studies have established a strong association between obstructive sleep…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take aim at stubborn autoimmune disorder
Disease control Not yet recruitingThis is a Phase I, single-arm, open-label, dose-escalation and dose-expansion study. This study evaluates the safety and efficacy of universal STAR-T cells in patients with R/R CTD-associated Immune Thrombocytopenia (CTD-ITP). Approximately 9 patients aged 18-65 will receive inf…
Phase: PHASE1 • Sponsor: Jian Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug combo aims to tame Cushing's disease with fewer side effects
Disease control ENROLLING_BY_INVITATIONCushing disease remains a challenging endocrine disorder in which persistent or recurrent hypercortisolism often requires medical therapy after surgery or when surgery is not feasible. Combination medical therapy has emerged as a rational strategy to improve biochemical control t…
Phase: PHASE4 • Sponsor: University of Basrah • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can cervical cancer patients stop immunotherapy early? new study investigates
Disease control Recruiting nowThis is a nationwide, multicenter, registry-based prospective cohort study to assess real-world effectiveness of treatment with a pembrolizumab containing regimen in persistent, recurrent, or metastatic cervical cancer. Patients in the observation cohort continue treatment accord…
Phase: PHASE4 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Light therapy wearables could ease Alzheimer's sleep troubles
Symptom relief ENROLLING_BY_INVITATIONBy 2025, Taiwan will become a super-aged society, with the number of Alzheimer's disease patients continuing to rise. However, the vast majority of dementia patients experience "behavioral and psychological symptoms of dementia" (BPSD), such as circadian rhythm disruptions and sl…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New oral painkiller aims to ease recovery after abdominal surgery
Symptom relief Recruiting nowThis clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery.
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New heart pump takes on impella in High-Stakes stenting trial
Disease control Recruiting nowThe objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational devic…
Phase: NA • Sponsor: Supira Medical • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New combo therapy for breast cancer aims to outsmart drug resistance
Disease control Recruiting nowSingle agent endocrine therapy (ET), with selective estrogen receptor degraders (SERDs; i.e. fulvestrant or elacestrant), is an option for patients with pre-treated hormone receptor-positive (HR+) breast cancer (BC) with indolent behaviour beyond the first line therapy with CDK4/…
Phase: PHASE2 • Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New combo vaccine for kids could replace current shot
⭐️ VACCINE ⭐️ Recruiting nowThis study is evaluating the immunogenicity and safety of intramuscular administration of the investigational MMRVNS vaccine compared to intramuscular administration of the MMRV (Merck's measles, mumps, rubella and varicella) vaccine (ProQuad) that is already licensed for this ro…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 10, 2026 00:00 UTC
-
New Antibody-Drug conjugate targets advanced cancers in first human trial
Disease control Recruiting nowThis is a Phase 1, open-label, multi-center, first-in-human, dose escalation and cohort expansion study evaluating multiple doses and schedules of intravenously administered QLS5212 in participants with unresectable locally, advanced or metastatic cancer.
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Second infusion of designer cells aims to rescue failing hearts
Disease control Recruiting nowThis study aims to evaluate the safety and preliminary efficacy of a second administration of fibroblast activation protein (FAP)-targeted immunosuppressive chimeric antigen receptor dendritic cells (CAR-DC) in patients with end-stage dilated cardiomyopathy. Previous clinical re…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Needle therapy tested for painful sex condition
Symptom relief Recruiting nowChronic vulvar pain is a highly prevalent and debilitating condition affecting up to 16% of women. The most common subtype of vulvar pain, provoked vestibulodynia (PVD), is characterized by a sharp pain at the entry of the vagina in response to pressure or attempted vaginal penet…
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can a coach help men with HIV stay healthy? south africa trial aims to find out
Disease control Not yet recruitingDeveloped in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide sup…
Phase: NA • Sponsor: University of Cape Town • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC